CLX-001
N/A
Report date: 2023/07/10 17:59:03
NME
Base Information
Drug NameCLX-001
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesCytosinLab Therapeutics Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesCytosinLab Therapeutics Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A